Pathophysiology and current treatment strategies to treat Endometriosis

In: International Journal of Pharma Professional's Research (IJPPR) · 2025 · vol. 16(1) , pp. 41–63 · doi:10.69580/ijppr.16.1.2025.41-63 · W4415914680
article OA: diamond CC0

Abstract

The development of endometrial-like tissue outside the uterine cavity distinguishes the disorder endometriosis, which affects women of reproductive age.Infertility and ongoing pelvic pain are usually present in conjunction with it.In spite of a variety of symptoms, endometriosis hypotheses, diagnoses, clearcut biomarkers, pathophysiology, and diagnoses endometriosis.For the treatment of symptomatic endometriosis, many therapies and analgesics are employed.Ovarian carcinomas, such as endometrioid and clear cell carcinomas, are more likely to occur in patients with ovarian endometriosis.Some of these carcinomas could develop in endometriotic foci that have structural and/or nuclear atypia.Endometriosis currently has no known cure; hence the majority of treatments focus on controlling chronic discomfort or infertility.A role for hormones, immune function, and genetic variables is also possible.In most patients, the disease involves pelvic organs, but rarely it may also extend to a large variety of distant locations in the body.Patients with ovarian endometriosis are at higher risk for developing ovarian carcinomas including endometrioid and clear cell carcinomas.In this article, we will go over the many symptoms, endometriosis hypotheses, diagnostics, unmistakable biomarkers, pathogenesis, and diagnosis as well as treatment options for symptomatic endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK